166 related articles for article (PubMed ID: 11273734)
1. Targeted deletion of the A3 adenosine receptor confers resistance to myocardial ischemic injury and does not prevent early preconditioning.
Guo Y; Bolli R; Bao W; Wu WJ; Black RG; Murphree SS; Salvatore CA; Jacobson MA; Auchampach JA
J Mol Cell Cardiol; 2001 Apr; 33(4):825-30. PubMed ID: 11273734
[TBL] [Abstract][Full Text] [Related]
2. The effect of body temperature on myocardial protection conferred by ischaemic preconditioning or the selective adenosine A1 receptor agonist GR79236, in an anaesthetized rabbit model of myocardial ischaemia and reperfusion.
Sheldrick A; Gray KM; Drew GM; Louttit JB
Br J Pharmacol; 1999 Sep; 128(2):385-95. PubMed ID: 10510449
[TBL] [Abstract][Full Text] [Related]
3. Gene dosage-dependent effects of cardiac-specific overexpression of the A3 adenosine receptor.
Black RG; Guo Y; Ge ZD; Murphree SS; Prabhu SD; Jones WK; Bolli R; Auchampach JA
Circ Res; 2002 Jul; 91(2):165-72. PubMed ID: 12142350
[TBL] [Abstract][Full Text] [Related]
4. The infarct-sparing effect of IB-MECA against myocardial ischemia/reperfusion injury in mice is mediated by sequential activation of adenosine A3 and A 2A receptors.
Tian Y; Marshall M; French BA; Linden J; Yang Z
Basic Res Cardiol; 2015 Mar; 110(2):16. PubMed ID: 25711314
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
[TBL] [Abstract][Full Text] [Related]
6. Reduction in infarct size by ischemic preconditioning persists in a chronic rat model of myocardial ischemia-reperfusion injury.
Lott FD; Guo P; Toombs CF
Pharmacology; 1996 Feb; 52(2):113-8. PubMed ID: 8851632
[TBL] [Abstract][Full Text] [Related]
7. Targeted deletion of A(3) adenosine receptors improves tolerance to ischemia-reperfusion injury in mouse myocardium.
Cerniway RJ; Yang Z; Jacobson MA; Linden J; Matherne GP
Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1751-8. PubMed ID: 11557567
[TBL] [Abstract][Full Text] [Related]
8. Comparison of three different A1 adenosine receptor antagonists on infarct size and multiple cycle ischemic preconditioning in anesthetized dogs.
Auchampach JA; Jin X; Moore J; Wan TC; Kreckler LM; Ge ZD; Narayanan J; Whalley E; Kiesman W; Ticho B; Smits G; Gross GJ
J Pharmacol Exp Ther; 2004 Mar; 308(3):846-56. PubMed ID: 14634049
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
[TBL] [Abstract][Full Text] [Related]
10. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor.
Ge ZD; Peart JN; Kreckler LM; Wan TC; Jacobson MA; Gross GJ; Auchampach JA
J Pharmacol Exp Ther; 2006 Dec; 319(3):1200-10. PubMed ID: 16985166
[TBL] [Abstract][Full Text] [Related]
11. Relative importance of adenosine A1 and A3 receptors in mediating physiological or pharmacological protection from ischemic myocardial injury in the rabbit heart.
Hill RJ; Oleynek JJ; Magee W; Knight DR; Tracey WR
J Mol Cell Cardiol; 1998 Mar; 30(3):579-85. PubMed ID: 9515033
[TBL] [Abstract][Full Text] [Related]
12. Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection.
Sánchez JA; Rodríguez-Sinovas A; Barba I; Miró-Casas E; Fernández-Sanz C; Ruiz-Meana M; Alburquerque-Béjar JJ; García-Dorado D
Basic Res Cardiol; 2013 May; 108(3):351. PubMed ID: 23595215
[TBL] [Abstract][Full Text] [Related]
13. The A3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-3'-aminoadenosine-5'-N-methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel.
Wan TC; Ge ZD; Tampo A; Mio Y; Bienengraeber MW; Tracey WR; Gross GJ; Kwok WM; Auchampach JA
J Pharmacol Exp Ther; 2008 Jan; 324(1):234-43. PubMed ID: 17906066
[TBL] [Abstract][Full Text] [Related]
14. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors.
Kerendi F; Kin H; Halkos ME; Jiang R; Zatta AJ; Zhao ZQ; Guyton RA; Vinten-Johansen J
Basic Res Cardiol; 2005 Sep; 100(5):404-12. PubMed ID: 15965583
[TBL] [Abstract][Full Text] [Related]
15. Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice.
Montecucco F; Lenglet S; Braunersreuther V; Pelli G; Pellieux C; Montessuit C; Lerch R; Deruaz M; Proudfoot AE; Mach F
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1371-7. PubMed ID: 20413731
[TBL] [Abstract][Full Text] [Related]
16. Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury.
Schulman D; Latchman DS; Yellon DM
Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1630-6. PubMed ID: 11557553
[TBL] [Abstract][Full Text] [Related]
17. Lack of adenosine causes myocardial refractoriness.
Vogt AM; Ando H; Arras M; Elsässer A
J Am Coll Cardiol; 1998 Apr; 31(5):1134-41. PubMed ID: 9562019
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with an adenosine A1 receptor agonist and lidocaine: a possible alternative to myocardial ischemic preconditioning.
Canyon SJ; Dobson GP
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):371-7. PubMed ID: 16077401
[TBL] [Abstract][Full Text] [Related]
19. Ability of CP-532,903 to protect mouse hearts from ischemia/reperfusion injury is dependent on expression of A
Wan TC; Tampo A; Kwok WM; Auchampach JA
Biochem Pharmacol; 2019 May; 163():21-31. PubMed ID: 30710517
[TBL] [Abstract][Full Text] [Related]
20. The role of TNF-alpha receptors p55 and p75 in acute myocardial ischemia/reperfusion injury and late preconditioning.
Flaherty MP; Guo Y; Tiwari S; Rezazadeh A; Hunt G; Sanganalmath SK; Tang XL; Bolli R; Dawn B
J Mol Cell Cardiol; 2008 Dec; 45(6):735-41. PubMed ID: 18824172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
